BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28125933)

  • 1. NANOG Restores Contractility of Mesenchymal Stem Cell-Based Senescent Microtissues.
    Shahini A; Mistriotis P; Asmani M; Zhao R; Andreadis ST
    Tissue Eng Part A; 2017 Jun; 23(11-12):535-545. PubMed ID: 28125933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NANOG Reverses the Myogenic Differentiation Potential of Senescent Stem Cells by Restoring ACTIN Filamentous Organization and SRF-Dependent Gene Expression.
    Mistriotis P; Bajpai VK; Wang X; Rong N; Shahini A; Asmani M; Liang MS; Wang J; Lei P; Liu S; Zhao R; Andreadis ST
    Stem Cells; 2017 Jan; 35(1):207-221. PubMed ID: 27350449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated markers in undifferentiated cells: expression of smooth muscle contractile proteins in multipotent bone marrow mesenchymal stem cells.
    Liu Y; Deng B; Zhao Y; Xie S; Nie R
    Dev Growth Differ; 2013 Jun; 55(5):591-605. PubMed ID: 23557080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetofection Mediated Transient NANOG Overexpression Enhances Proliferation and Myogenic Differentiation of Human Hair Follicle Derived Mesenchymal Stem Cells.
    Son S; Liang MS; Lei P; Xue X; Furlani EP; Andreadis ST
    Bioconjug Chem; 2015 Jul; 26(7):1314-27. PubMed ID: 25685943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smooth Muscle-Like Cells Generated from Human Mesenchymal Stromal Cells Display Marker Gene Expression and Electrophysiological Competence Comparable to Bladder Smooth Muscle Cells.
    Brun J; Lutz KA; Neumayer KM; Klein G; Seeger T; Uynuk-Ool T; Wörgötter K; Schmid S; Kraushaar U; Guenther E; Rolauffs B; Aicher WK; Hart ML
    PLoS One; 2015; 10(12):e0145153. PubMed ID: 26673782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential.
    Han J; Mistriotis P; Lei P; Wang D; Liu S; Andreadis ST
    Stem Cells; 2012 Dec; 30(12):2746-59. PubMed ID: 22949105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring extracellular matrix synthesis in senescent stem cells.
    Rong N; Mistriotis P; Wang X; Tseropoulos G; Rajabian N; Zhang Y; Wang J; Liu S; Andreadis ST
    FASEB J; 2019 Oct; 33(10):10954-10965. PubMed ID: 31287964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells reverse hypoxia-mediated suppression of α-smooth muscle actin expression in human dermal fibroblasts.
    Faulknor RA; Olekson MA; Nativ NI; Ghodbane M; Gray AJ; Berthiaume F
    Biochem Biophys Res Commun; 2015 Feb; 458(1):8-13. PubMed ID: 25625213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-145-based differentiation of human mesenchymal stem cells to smooth muscle cells.
    Pajoohesh M; Naderi-Manesh H; Soleimani M
    Biotechnol Lett; 2016 Nov; 38(11):1975-1981. PubMed ID: 27439694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphology and contractile gene expression of adipose-derived mesenchymal stem cells in response to short-term cyclic uniaxial strain and TGF-β1.
    Rashidi N; Tafazzoli-Shadpour M; Haghighipour N; Khani MM
    Biomed Tech (Berl); 2018 Jun; 63(3):317-326. PubMed ID: 28704177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional effects of organismal ageing on smooth muscle cells derived from bone marrow mesenchymal stem cells.
    Han J; Liu JY; Swartz DD; Andreadis ST
    Cardiovasc Res; 2010 Jul; 87(1):147-55. PubMed ID: 20097675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2.
    Pierantozzi E; Gava B; Manini I; Roviello F; Marotta G; Chiavarelli M; Sorrentino V
    Stem Cells Dev; 2011 May; 20(5):915-23. PubMed ID: 20879854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D culture increases pluripotent gene expression in mesenchymal stem cells through relaxation of cytoskeleton tension.
    Zhou Y; Chen H; Li H; Wu Y
    J Cell Mol Med; 2017 Jun; 21(6):1073-1084. PubMed ID: 28276635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and trans-differentiation of mesenchymal stromal cells into smooth muscle cells: Utility and applicability for cell-sheet engineering.
    Shudo Y; Cohen JE; Goldstone AB; MacArthur JW; Patel J; Edwards BB; Hopkins MS; Steele AN; Joubert LM; Miyagawa S; Sawa Y; Woo YJ
    Cytotherapy; 2016 Apr; 18(4):510-7. PubMed ID: 26971679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NANOG has a role in mesenchymal stem cells' immunomodulatory effect.
    Sun Z; Han Q; Zhu Y; Li Z; Chen B; Liao L; Bian C; Li J; Shao C; Zhao RC
    Stem Cells Dev; 2011 Sep; 20(9):1521-8. PubMed ID: 21235326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue.
    Vidal MA; Walker NJ; Napoli E; Borjesson DL
    Stem Cells Dev; 2012 Jan; 21(2):273-83. PubMed ID: 21410356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization and transcriptome analysis of embryonic stem cell-derived contractile smooth muscle cells.
    Potta SP; Liang H; Pfannkuche K; Winkler J; Chen S; Doss MX; Obernier K; Kamisetti N; Schulz H; Hübner N; Hescheler J; Sachinidis A
    Hypertension; 2009 Feb; 53(2):196-204. PubMed ID: 19064816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stretching human mesenchymal stromal cells on stiffness-customized collagen type I generates a smooth muscle marker profile without growth factor addition.
    Rothdiener M; Hegemann M; Uynuk-Ool T; Walters B; Papugy P; Nguyen P; Claus V; Seeger T; Stoeckle U; Boehme KA; Aicher WK; Stegemann JP; Hart ML; Kurz B; Klein G; Rolauffs B
    Sci Rep; 2016 Oct; 6():35840. PubMed ID: 27775041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage.
    Narita Y; Yamawaki A; Kagami H; Ueda M; Ueda Y
    Cell Tissue Res; 2008 Sep; 333(3):449-59. PubMed ID: 18607632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of xenogenic-free expansion media significantly influences the myogenic differentiation potential of human bone marrow-derived mesenchymal stromal cells.
    Brun J; Abruzzese T; Rolauffs B; Aicher WK; Hart ML
    Cytotherapy; 2016 Mar; 18(3):344-59. PubMed ID: 26857228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.